Pharmabiz5d
SineuGene Therapeutics receives US FDA’s investigational new drug application clearance for SNUG01 to treat amyotrophic lateral sclerosis
SineuGene Therapeutics receives US FDA’s investigational new drug application clearance for SNUG01 to treat amyotrophic lateral sclerosis: Beijing Thursday, March 27, 2025, 15:0 ...
Nature3mon
A curated compendium of phosphorylation motifs
Until now, however, there has been no single resource that allows investigators to determine whether a protein/peptide of interest contains a motif that has been previously described in the ...
Nature1y
Paxillin LD motifs may define a new family of protein recognition domains
Cells assemble protein networks through regions of protein recognition that are found in numerous proteins as conserved peptide motifs. This allows for the specific and efficient communication of ...
Hosted on MSN6mon
Exploring the role of chemokines in atrial fibrillation development
Chemokines are a subclass of cytokines, a large family of small secreted proteins that communicate ... persistent AF have higher levels of C-X-C motif chemokine ligand 8 (CXCL8) than those with ...
BioWorld8d
Sineugene’s TRIM72-targeted gene therapy for ALS gains IND clearance from FDA
Sineugene Therapeutics Co. Ltd. has obtained IND clearance from the FDA for SNUG-01, a first-in-class tripartite motif ...
The Scientist2y
Infographic: Short Protein Motifs’ Role in SARS-CoV-2 Infection
One type of protein interaction mediated by the unstructured proteome involves short linear motifs (SLiMs), abundant stretches of up to 10 amino acids. Their interactions with other proteins are ...
PipelineReview.com8d
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS
BEIJING, China I March 24, 2025 I SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for ...